Cytosine Arabinoside With Daunorubicin or Adriamycin for Therapy of Acute Myelocytic Leukemia: A CALGB Study

A randomized comparison of the relative efficacy and toxicity of daunorubicin (DNR) at 30 or 45 mg/sq m or adriamycin (ADM) at 30 mg/sq m, given on the first 3 days of a 7-day continuous infusion of cytosine arabinoside (ara-C) at 100 mg/sq m/day. shows the outcome to be dependent on anthracycline,...

Full description

Saved in:

Bibliographic Details
Published in:	Blood Vol. 60; no. 2; pp. 454 - 462
Main Authors:	Yates, Jerome, Glidewell, Oliver, Wiernik, Peter, Cooper, M.Robert, Steinberg, David, Dosik, Harvey, Levy, Robert, Hoagland, Clark, Henry, Patrick, Gottlieb, Arlan, Cornell, Cornelius, Berenberg, Jeffrey, Hutchison, J.Lawrence, Raich, Peter, Nissen, Nis, Ellison, Rose Ruth, Frelick, Robert, James, G.Watson, Falkson, Geoffrey, Silver, Richard T., Haurani, Farid, Green, Mark, Henderson, Edward, Leone, Louis, Holland, James F.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-08-1982
Subjects:	Adolescent Adult Age Factors Aged Child Child, Preschool Colitis, Ulcerative - chemically induced Cytarabine - adverse effects Cytarabine - therapeutic use Daunorubicin - adverse effects Daunorubicin - therapeutic use Dose-Response Relationship, Drug Doxorubicin - adverse effects Doxorubicin - therapeutic use Drug Administration Schedule Drug Therapy, Combination Female Humans Infant Leukemia, Myeloid, Acute - drug therapy Male Middle Aged Stomatitis - chemically induced
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A randomized comparison of the relative efficacy and toxicity of daunorubicin (DNR) at 30 or 45 mg/sq m or adriamycin (ADM) at 30 mg/sq m, given on the first 3 days of a 7-day continuous infusion of cytosine arabinoside (ara-C) at 100 mg/sq m/day. shows the outcome to be dependent on anthracycline, dose, and patient age. DNR 45 is significantly better than DNR 30 or ADM 30 for inducing complete remissions (CR) in patients younger than 60 yr, (72%. 59%. 58% CRs. respectively). DNR 30 is better than DNR 45 or ADM 30 for inducing CR in patients older than 60 yr (47%, 31 %, 35%. respectively). There was a corresponding shift in the induction mortality for the age. dose, and anthracycline groups. Adriamycin was significantly more toxic to the gastrointestinal tract than daunorubicin. The duration of complete remission, with cyclic courses of maintenance therapy, was independent of the patient's age. the dose, or choice of anthracycline used in induction, and of whether the maintenance courses were given every 4 wk or every 8 wk.
ISSN:	0006-4971 1528-0020
DOI:	10.1182/blood.V60.2.454.454